Bayer may hit with a lawsuit over misrepresentation of cancer benefits of a vitamin drug

Bayer-Oneaday-mens-vitaminA leading consumer advocacy group is all set to sue Bayer if it refuses to stop the wrongful claim about the ability of its vitamin drug named, ‘One A Day Vitamin’.

According to a nonprofit organisation, ‘Center for Science in the Public Interest’,Bayer is using television and radio to spread its wrongful claim that their  vitamin suppliment could reduce the risk of prostate cancer in men.

A formal complaint has already filed by the center with the Federal Trade Commission, which regulates advertising claims and is threatening to file a lawsuit seeking to force Bayer to drop or modify the One A Day advertising claims.

National Institutes of Health has found no proof that the ingredient in the vitamins, selenium, actually prevents the cancer.

As per prostate cancer prevention trial, which is a largest trial of its kind, has observed that selenium is no more effective than a placebo. But Bayer advertises One A Day Men’s 50+ Advantage and One A Day Men’s Health Formula multivitamins by claiming “emerging research” suggests that selenium can lower prostate cancer risks. The claims appear on the vitamins package labels, TV and radio ads, and on the company’s Web site.

Another large study on the same subject was postponed on Oct 2008 as researchers found that the mineral not preventing cancer and in addition may help develop diabetes.

The consumer advocacy group called Bayer’s claims of selenium benefits for men in fighting prostate cancer “astounding” and “deceptive.”

However, according to the Bayer’s global spoke man Trish McKernan, They will standing behind all the claims they make in support of the products, as the claims of prostate cancer benefits are supported by the Food and Drug Administration.

Source: attorney at law

Related?

Leave a Reply


Protected by Comment Guard Pro